uridine diphosphate has been researched along with Disease Models, Animal in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 14 (70.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Arena, P; Attanasio, S; Boffa, I; Brunetti-Pierri, N; Cuomo, P; D'Alessio, AM; De Angelis, A; Desviat, LR; Ferenbach, AT; Häberle, J; Lipshutz, GS; Makris, G; Martínez-Pizarro, A; Motta, A; Nitzahn, M; Nusco, E; Paris, D; Pravata, VM; Richard, E; Rüfenacht, V; Soria, LR; van Aalten, DMF | 1 |
| Arumugam, TV; Jo, DG; Lai, MKP; Park, J | 1 |
| Belosludtseva, NV; Bulion, VV; Evdokimova, NR; Krylova, IB; Mironova, GD; Rodionova, OM; Selina, EN; Shigaeva, MI | 1 |
| Harada, T; Iwata, T; Kashiwagi, K; Koizumi, S; Namekata, K; Ohno, N; Robaye, B; Shinozaki, Y; Takeda, A | 1 |
| Akerley, BJ; Jackson, MD; Wong, SM | 1 |
| Ayata, CK; Bode, C; Cicko, S; Dufner, B; Grimm, M; Hergeth, S; Hoppe, N; Idzko, M; Marchini, T; Michel, NA; Peikert, A; Reinöhl, J; Schulte, L; Stachon, P; von zur Muhlen, C; Wolf, D; Zirlik, A | 1 |
| Schiffmann, R | 1 |
| Aerts, JM; Archer, J; Cox, TM; Dekker, N; Karlsson, S; Pavlova, EV; Wang, S | 1 |
| Du, B; Li, R; Liu, M; Ma, X; Qian, M; Tan, B; Yan, Y; Zhang, N; Zhang, Z | 1 |
| Bremser, S; Brüning, JC; Evers, N; Hinze, Y; Idzko, M; Kloppenburg, P; Paeger, L; Steculorum, SM | 1 |
| Du, B; Liu, M; Lv, Z; Qian, M; Qin, J; Ren, H; Tan, B; Zhang, G; Zhang, X | 1 |
| Abraham, P; Ayer, A; Billaud, M; Boeynaems, JM; de Wit, C; Grimaud, L; Henrion, D; Isakson, BE; Kauffenstein, G; Kwak, BR; Loufrani, L; Monyer, H; Procaccio, V; Prunier, F; Robaye, B; Rousseau, P; Roy, C; Tamareille, S; Toutain, B | 1 |
| Hayashi, Y; Liu, Y; Nakanishi, H; Takayama, F; Wu, Z | 1 |
| Chen, LL; Du, B; Jiang, WZ; Qian, M; Ren, H; Shi, JP; Wang, SY; Zhang, XY; Zhao, YH | 1 |
| Bremser, S; Brüning, JC; Engström Ruud, L; Evers, N; Kloppenburg, P; Paeger, L; Steculorum, SM; Timper, K | 1 |
| Matsumoto, T; Tostes, RC; Webb, RC | 1 |
| Alam, SN; Hamarneh, SR; Hodin, RA; Hohmann, E; Kaliannan, K; Malo, MS; Malo, NS; Millán, JL; Moaven, O; Mohamed, MM; Moss, AK; Muhammad, N; Narisawa, S; Patel, P; Ramasamy, S; Teshager, A; Warren, HS; Yammine, H | 1 |
| Minami, M; Nakagawa, T; Okada, M; Satoh, M | 1 |
| Atucha, N; De Rycker, M; García-Estañ, J; Iyu, D; Soler, A | 1 |
2 review(s) available for uridine diphosphate and Disease Models, Animal
| Article | Year |
|---|---|
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Topics: Acetylglucosamine; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Molecular Structure; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Isoforms; Protein Processing, Post-Translational; Stroke; tau Proteins; Uridine Diphosphate; Uridine Diphosphate N-Acetylgalactosamine | 2020 |
The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.
Topics: Animals; Asthma; Atherosclerosis; Diabetes Mellitus; Disease Models, Animal; Glucose; Glucosyltransferases; Humans; Lipid Metabolism; Lysosomes; Mice; Polycystic Kidney Diseases; Serine C-Palmitoyltransferase; Sphingolipidoses; Sphingolipids; Uridine Diphosphate | 2015 |
18 other study(ies) available for uridine diphosphate and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis.
Topics: Acetylglucosamine; Ammonia; Animals; Biocatalysis; Carbamoyl-Phosphate Synthase (Ammonia); Disease Models, Animal; Glycosylation; Humans; Hyperammonemia; Mammals; Mice; N-Acetylglucosaminyltransferases; Propionic Acidemia; Protein Processing, Post-Translational; Urea; Uridine Diphosphate | 2022 |
Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia/reperfusion by activating the mitochondrial ATP-dependent potassium channel.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Antioxidants; Arrhythmias, Cardiac; Disease Models, Animal; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Rats, Wistar; Tachycardia; Uridine; Uridine Diphosphate; Uridine Triphosphate; Ventricular Fibrillation | 2021 |
Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
Topics: Aging; Animals; Aqueous Humor; Ciliary Body; Disease Models, Animal; Dose-Response Relationship, Drug; Glaucoma; Intraocular Pressure; Mice, Knockout; Optic Nerve Diseases; Receptors, Purinergic P2; Retinal Ganglion Cells; Signal Transduction; Uridine Diphosphate | 2017 |
Suppression of Alternative Lipooligosaccharide Glycosyltransferase Activity by UDP-Galactose Epimerase Enhances Murine Lung Infection and Evasion of Serum IgM.
Topics: Animals; Bacterial Proteins; Biofilms; Complement System Proteins; Disease Models, Animal; Gene Deletion; Gene Expression; Glycosyltransferases; Haemophilus Infections; Haemophilus influenzae; Humans; Immune Evasion; Immunoglobulin M; Lipopolysaccharides; Lung; Mice; UDPglucose 4-Epimerase; Uridine Diphosphate; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose; Virulence | 2019 |
P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Bone Marrow Transplantation; Cholesterol, Dietary; Disease Models, Animal; Inflammation; Inflammation Mediators; Leukocyte Rolling; Macrophages; Mice; Mice, Knockout; Plaque, Atherosclerotic; Receptors, LDL; Receptors, Purinergic P2; Signal Transduction; Time Factors; Transendothelial and Transepithelial Migration; Uridine Diphosphate | 2014 |
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy.
Topics: Animals; Disease Models, Animal; Female; Gaucher Disease; Glucosyltransferases; Lymphoma, B-Cell; Male; Mice; Pyrrolidines; Uridine Diphosphate | 2015 |
Extracellular UDP and P2Y6 function as a danger signal to protect mice from vesicular stomatitis virus infection through an increase in IFN-β production.
Topics: Activating Transcription Factor 2; Animals; Apoptosis; Cell Line; Cells, Cultured; Connexins; Disease Models, Animal; Female; Gap Junctions; Gene Expression; Humans; Interferon-beta; JNK Mitogen-Activated Protein Kinases; Macrophages; Mice; Mice, Knockout; Models, Biological; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Receptors, Purinergic P2; Signal Transduction; Uridine Diphosphate; Vesicular Stomatitis; Vesiculovirus; Virus Replication | 2014 |
Hypothalamic UDP Increases in Obesity and Promotes Feeding via P2Y6-Dependent Activation of AgRP Neurons.
Topics: Agouti-Related Protein; Animals; Appetite Regulation; Disease Models, Animal; Hypothalamus; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Obesity; Receptors, Purinergic P2; Uridine Diphosphate | 2015 |
TLR-Activated Gap Junction Channels Protect Mice against Bacterial Infection through Extracellular UDP Release.
Topics: Animals; Blotting, Western; Connexin 43; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Escherichia coli Infections; Female; Gap Junctions; Immunity, Innate; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Signal Transduction; Toll-Like Receptor 4; Toll-Like Receptors; Uridine Diphosphate | 2016 |
Central Role of P2Y6 UDP Receptor in Arteriolar Myogenic Tone.
Topics: Adenosine Triphosphatases; Animals; Arterioles; Blood Pressure; Calcium Signaling; Cells, Cultured; Connexin 43; Disease Models, Animal; Dose-Response Relationship, Drug; Genotype; Heart Failure; Hydrolysis; Mechanotransduction, Cellular; Mesentery; Mice, Knockout; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocardial Infarction; Myocytes, Smooth Muscle; Myosin Light Chains; Phenotype; Phosphorylation; Purinergic P2X Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Uridine Diphosphate; Vasoconstriction; Vasoconstrictor Agents | 2016 |
Diurnal dynamic behavior of microglia in response to infected bacteria through the UDP-P2Y6 receptor system.
Topics: Animals; Brain; Cell Surface Extensions; Circadian Rhythm; Disease Models, Animal; Meningoencephalitis; Mice, Inbred C57BL; Microglia; Porphyromonas gingivalis; Receptors, Purinergic P2; Uridine Diphosphate | 2016 |
P2Y6 contributes to ovalbumin-induced allergic asthma by enhancing mast cell function in mice.
Topics: Animals; Asthma; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Chemotaxis; Cytokines; Disease Models, Animal; Hypersensitivity; Immunoglobulin E; Inflammation; Interleukin-4; Mast Cells; Mice; Mice, Inbred C57BL; Ovalbumin; Phenotype; Real-Time Polymerase Chain Reaction; Receptors, Purinergic P2; Signal Transduction; Uridine Diphosphate | 2016 |
Inhibition of P2Y6 Signaling in AgRP Neurons Reduces Food Intake and Improves Systemic Insulin Sensitivity in Obesity.
Topics: Agouti-Related Protein; Animals; Diet; Disease Models, Animal; Eating; Feeding Behavior; Hyperphagia; Insulin; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neurons; Obesity; Receptors, Purinergic P2; Signal Transduction; Uridine Diphosphate | 2017 |
Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Arteries; Basilar Artery; Desoxycorticosterone; Dinucleoside Phosphates; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Femoral Artery; Hypertension; Male; Mesenteric Arteries; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Sodium Chloride, Dietary; Uridine Diphosphate; Uridine Triphosphate; Vasoconstriction; Vasoconstrictor Agents | 2012 |
Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphate.
Topics: Alkaline Phosphatase; Animals; Bacterial Proteins; Cells, Cultured; Disease Models, Animal; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-8; Intestinal Mucosa; Intestine, Small; Lipopolysaccharides; Mice; Mice, Knockout; Receptors, Purinergic P2; Uridine Diphosphate | 2013 |
Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats.
Topics: Adenosine Triphosphate; Analgesics; Animals; Disease Models, Animal; Hot Temperature; Injections, Spinal; Male; Neuralgia; Pain; Posture; Pressure; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Time Factors; Uridine; Uridine Diphosphate; Uridine Monophosphate; Uridine Triphosphate | 2002 |
Altered calcium regulation in freshly isolated aortic smooth muscle cells from bile duct-ligated rats: role of nitric oxide.
Topics: Adenosine Triphosphate; Animals; Aorta; Bile Ducts; Calcium; Calcium Signaling; Cells, Cultured; Cholestasis; Disease Models, Animal; Fura-2; Hypotension; Liver Cirrhosis, Experimental; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reaction Time; Regional Blood Flow; Uridine Diphosphate; Vasoconstriction | 2003 |